Alkermes (ALKS) EBIT (2010 - 2026)
Alkermes (ALKS) recorded EBIT of $36.02 million in Q3 2026, down 59.6% from $89.08 million a year earlier but up 96.3% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) EBIT (2010 - 2026) Analysis & Trends
On a TTM basis, Alkermes' EBIT came in at $64.2 million as of Sep 30, 2026, down 82.1% year-over-year; for FY2025, it was $253.96 million, down 39.6% from FY2024.
- Across earlier years, EBIT came in at $420.64 million in FY2024 (+1.6%), $414.12 million in FY2023, -$6.09 million in FY2022 and $97.75 million in FY2021.
- Quarterly EBIT has ranged from -$60.64 million in Q3 2022 to $281.27 million in Q2 2023 over the past five years.
- On a year-over-year basis, EBIT rose in 1 of the last seven quarters, with an average decline of 15.0%.
- Peak year-over-year performance for EBIT in the last five years was growth of 197.8% in Q4 2024, against a decline of 80.3% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $18.35 million (Q2 2026), -$48.28 million (Q1 2026) and $58.1 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn | 36.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 36.02 Mn |
| Jun 30, 2026 | 18.35 Mn |
| Mar 31, 2026 | -48.28 Mn |
| Dec 31, 2025 | 58.10 Mn |
| Sep 30, 2025 | 89.08 Mn |
| Jun 30, 2025 | 92.98 Mn |
| Mar 31, 2025 | 13.79 Mn |
| Dec 31, 2024 | 162.69 Mn |
| Sep 30, 2024 | 104.76 Mn |
| Jun 30, 2024 | 109.88 Mn |
| Mar 31, 2024 | 43.31 Mn |
| Dec 31, 2023 | 54.63 Mn |
| Sep 30, 2023 | 89.19 Mn |
| Jun 30, 2023 | 281.27 Mn |
| Mar 31, 2023 | -10.97 Mn |
| Dec 31, 2022 | 115.59 Mn |
| Sep 30, 2022 | -60.64 Mn |
| Jun 30, 2022 | -34.46 Mn |
| Mar 31, 2022 | -26.59 Mn |
| Dec 31, 2021 | 129.42 Mn |
API Access
Alkermes EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();